Genome editing reagent launched for disease model generation

November 30, 2015

AMSBIO has launched DNA-In® CRISPR – an innovative transfection reagent that simplifies and accelerates genome editing using large plasmids and difficult-to-transfect cells for life science researchers generating disease models.

Previous Article
New Start Detox receives CARF Accreditation
New Start Detox receives CARF Accreditation

New Start Detox has been issued a Three-Year CARF Accreditation. This achievement is an indication of New S...

Next Article
FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma
FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with...